Previous close | 9.20 |
Open | N/A |
Bid | 5.50 |
Ask | 7.10 |
Strike | 230.00 |
Expiry date | 2025-01-17 |
Day's range | 9.20 - 9.20 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Westlake's (WLK) action builds on the company's commitment to contributing to a more sustainable future through continual development of its own manufacturing as well as strategic investments.
BD (BDX) announces the commercial launch of its new single-cell research tool, BD Rhapsody ATAC-Seq Assay, to help researchers understand DNA regulation.
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.